Resolomics

Resolomics is a biotechnology company developing innovative, high-value companion diagnostics and a novel cell-based therapy. Our proprietary technology can identify specific molecules, lipid mediators, that are directly associated with both the initiation and resolution of inflammation, thereby enabling segmentation of the inflammatory events associated with a specific disease or drug. This Lipid Mediator Signature (LMS) technology has application across all inflammatory diseases, both chronic and acute and will significantly impact patient management and treatment.